New York-based provider of reproductive genetic testing and fertility services for IVF patients and fertility clinics.
Founded in 2011 and headquartered in New York, US, Recombine, Inc. offers reproductive genetic testing for patients undergoing in vitro fertilization (IVF), along with genetic counseling and educational materials, sold on a B2B basis to fertility clinics and healthcare providers. The company operates laboratories in New Jersey and London. It has raised a total of USD 8.44 mn, mainly in a July 2016 deal led by FirstMark Capital, across three deals.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in